
Overview
Yoshimi Ishii practices in Yokohama, Japan. Mr. Ishii is rated as an Advanced expert by MediFind in the treatment of B-Cell Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Bone Marrow Transplant, and Endoscopic Transnasal Transsphenoidal Surgery.
His clinical research consists of co-authoring 51 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 15 articles in the study of B-Cell Lymphoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- B-Cell LymphomaMr. Ishii isAdvanced. Learn about B-Cell Lymphoma.
- Bone Marrow TransplantMr. Ishii isAdvanced. Learn about Bone Marrow Transplant.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Non-Hodgkin LymphomaMr. Ishii isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Mr. Ishii isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Mr. Ishii isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisMr. Ishii isExperienced. Learn about Agranulocytosis.
- Angioimmunoblastic T-cell LymphomaMr. Ishii isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Bone TumorMr. Ishii isExperienced. Learn about Bone Tumor.
- Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy